Difference between revisions of "Preconditioning"

Line 30: Line 30:
 
| style="border: 1pt solid windowtext; width: 52px;" | <p style="text-align: center;"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Casarotto A</span></span></span></p>  
 
| style="border: 1pt solid windowtext; width: 52px;" | <p style="text-align: center;"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Casarotto A</span></span></span></p>  
 
| style="border:solid windowtext 1.0pt" | <p style="text-align: center;"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Nasole E</span></span></span></p>  
 
| style="border:solid windowtext 1.0pt" | <p style="text-align: center;"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Nasole E</span></span></span></p>  
−
| style="border:solid windowtext 1.0pt" | <p style="text-align: center;"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Preconditioning with hyperbaric oxygen in pancreatodudenectomy: a randomised double-blind pilot study</span></span></span></p>
+
| style="border:solid windowtext 1.0pt" |  
−
| style="border:solid windowtext 1.0pt" | <p style="text-align: center;"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Anticancer research 2014:2899-2960</span></span></span></p>
+
<span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Preconditioning with hyperbaric oxygen in pancreatodudenectomy: a randomised double-blind pilot study</span></span></span>
 +
 
 +
| style="border:solid windowtext 1.0pt" |  
 +
<span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Anticancer research 2014:2899-2960</span></span></span>
 +
 
 
| style="border:solid windowtext 1.0pt" | <p style="text-align: center;"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Preconditioning</span></span></span></p>  
 
| style="border:solid windowtext 1.0pt" | <p style="text-align: center;"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Preconditioning</span></span></span></p>  
 
| style="border:solid windowtext 1.0pt" | <p style="text-align: center;"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Panreatectomy</span></span></span></p>  
 
| style="border:solid windowtext 1.0pt" | <p style="text-align: center;"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Panreatectomy</span></span></span></p>  
Line 39: Line 43:
 
| style="border: 1pt solid windowtext; width: 52px;" | <p style="text-align: center;"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Dong H</span></span></span></p>  
 
| style="border: 1pt solid windowtext; width: 52px;" | <p style="text-align: center;"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Dong H</span></span></span></p>  
 
| style="border:solid windowtext 1.0pt" | <p style="text-align: center;"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Chen M</span></span></span></p>  
 
| style="border:solid windowtext 1.0pt" | <p style="text-align: center;"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Chen M</span></span></span></p>  
−
| style="border:solid windowtext 1.0pt" | <p style="text-align: center;"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Preconditioning with repeated hyperbaric oxygen induces myocardial and cerebral protection in patients undergoing coronary artery bypass graft surgery: a prospective, randomized, controlled clinical trial.</span></span></span></p>
+
| style="border:solid windowtext 1.0pt" |  
−
| style="border:solid windowtext 1.0pt" | <p style="text-align: center;"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Journal of cardiothoracic and vascular anesthesia. 2011 Dec 31;25(6):908-16.</span></span></span></p>
+
<span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Preconditioning with repeated hyperbaric oxygen induces myocardial and cerebral protection in patients undergoing coronary artery bypass graft surgery: a prospective, randomized, controlled clinical trial.</span></span></span>
 +
 
 +
| style="border:solid windowtext 1.0pt" |  
 +
<span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Journal of cardiothoracic and vascular anesthesia. 2011 Dec 31;25(6):908-16.</span></span></span>
 +
 
 
| style="border:solid windowtext 1.0pt" | <p style="text-align: center;"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Preconditioning</span></span></span></p>  
 
| style="border:solid windowtext 1.0pt" | <p style="text-align: center;"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Preconditioning</span></span></span></p>  
 
| style="border:solid windowtext 1.0pt" | <p style="text-align: center;"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">CABG</span></span></span></p>  
 
| style="border:solid windowtext 1.0pt" | <p style="text-align: center;"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">CABG</span></span></span></p>  
Line 48: Line 56:
 
| style="border: 1pt solid windowtext; width: 52px; text-align: center;" | <span style="font-size:medium;">Laden G</span>
 
| style="border: 1pt solid windowtext; width: 52px; text-align: center;" | <span style="font-size:medium;">Laden G</span>
 
| style="border: 1pt solid windowtext; text-align: center;" | <span style="font-size:medium;">Cale A</span>
 
| style="border: 1pt solid windowtext; text-align: center;" | <span style="font-size:medium;">Cale A</span>
−
| style="border: 1pt solid windowtext; text-align: center;" | <span style="font-size:medium;">Pretreatment with hyperbaric oxygen and its effect on neuropsychometric dysfunction and systemic inflammatory response after cardiopulmonary bypass: A prospective randomised double-blind trial.</span>
+
| style="border: 1pt solid windowtext;" | <span style="font-size:medium;">Pretreatment with hyperbaric oxygen and its effect on neuropsychometric dysfunction and systemic inflammatory response after cardiopulmonary bypass: A prospective randomised double-blind trial.</span>
−
| style="border: 1pt solid windowtext; text-align: center;" | <span style="font-size:medium;">Journal of Thoracic and Cardiovascular Surgery 2005;130(6):1623-30</span>
+
| style="border: 1pt solid windowtext;" | <span style="font-size:medium;">Journal of Thoracic and Cardiovascular Surgery 2005;130(6):1623-30</span>
 
| style="border: 1pt solid windowtext; text-align: center;" | <span style="font-size:medium;">Preconditioning</span>
 
| style="border: 1pt solid windowtext; text-align: center;" | <span style="font-size:medium;">Preconditioning</span>
 
| style="border: 1pt solid windowtext; text-align: center;" | <span style="font-size:medium;">Cardiac</span>
 
| style="border: 1pt solid windowtext; text-align: center;" | <span style="font-size:medium;">Cardiac</span>
 
| style="border: 1pt solid windowtext; text-align: center;" | <span style="font-size:medium;">cerebral</span>
 
| style="border: 1pt solid windowtext; text-align: center;" | <span style="font-size:medium;">cerebral</span>
 +
|-
 +
| style="border: 1pt solid windowtext; width: 65px; text-align: center;" | <span style="font-size:medium;">[[Yogaratnam|Yogaratnam JZ]]</span>
 +
| style="border: 1pt solid windowtext; width: 52px; text-align: center;" | <span style="font-size:medium;">Laden G</span>
 +
| style="border: 1pt solid windowtext; text-align: center;" | <span style="font-size:medium;">Madden LA</span>
 +
| style="border: 1pt solid windowtext;" | <span style="font-size:medium;">Hyperbaric oxygen preconditioning promotes cardioprotection following ischemic reperfusion injury by improving myocardial function, limiting necrosis and enhancing the induction of Hsp72.</span>
 +
| style="border: 1pt solid windowtext;" | <span style="font-size:medium;">Undersea and Hyperbaric Medicine 2007; 34(4):301-302</span>
 +
| style="border: 1pt solid windowtext; text-align: center;" | <span style="font-size:medium;">Cardiac</span>
 +
| style="border: 1pt solid windowtext; text-align: center;" | <span style="font-size:medium;">Cerebral</span>
 +
| style="border: 1pt solid windowtext; text-align: center;" | <span style="font-size:medium;">Reperfusion</span>
 
|}
 
|}
  

Revision as of 03:52, 27 September 2021

Preconditioning

HOME INDEX SEARCH DATABASE WHAT IS A CAT? WHAT CAN YOU DO? INTRODUCTION HBO EXPLAINED

 

Preoperative HBOT for improving clinical outcomes after major surgery

RTENOTITLE

Last searched December 2020

Author 1

Author 2

Author 3

Title

Citation

Search

term 1

Search

term 2

Search term 3

Bosco 2014

Casarotto A

Nasole E

Preconditioning with hyperbaric oxygen in pancreatodudenectomy: a randomised double-blind pilot study

Anticancer research 2014:2899-2960

Preconditioning

Panreatectomy

pilot

Li Y

Dong H

Chen M

Preconditioning with repeated hyperbaric oxygen induces myocardial and cerebral protection in patients undergoing coronary artery bypass graft surgery: a prospective, randomized, controlled clinical trial.

Journal of cardiothoracic and vascular anesthesia. 2011 Dec 31;25(6):908-16.

Preconditioning

CABG

cerebral

Alex J Laden G Cale A Pretreatment with hyperbaric oxygen and its effect on neuropsychometric dysfunction and systemic inflammatory response after cardiopulmonary bypass: A prospective randomised double-blind trial. Journal of Thoracic and Cardiovascular Surgery 2005;130(6):1623-30 Preconditioning Cardiac cerebral
Yogaratnam JZ Laden G Madden LA Hyperbaric oxygen preconditioning promotes cardioprotection following ischemic reperfusion injury by improving myocardial function, limiting necrosis and enhancing the induction of Hsp72. Undersea and Hyperbaric Medicine 2007; 34(4):301-302 Cardiac Cerebral Reperfusion

 

 

HOME INDEX SEARCH DATABASE WHAT IS A CAT?

WHAT CAN YOU DO? INTRODUCTION HBO EXPLAINED

RTENOTITLE

BACK